arrow
J

Jennifer S. Herrick

Utah System of Higher Education
H指数:49
被引数:7,523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States

在美国实施强化收缩压目标的年度成本

2024-09-170
OAAI
New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT
2023-09-050
OAAI
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults
2023-06-286
PRE
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020
2023-05-0132
OA
Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial

降压药物治疗方案在收缩压干预试验中的应用

2023-03-015
PRE
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019
2022-12-0110
OA
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
2022-07-145
OAAI
Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018

美国成年人治疗高血压和未控制血压的抗高血压单一疗法的相关因素总体和种族/民族,国家健康和营养检查调查2013-2018

2022-06-011
OAAI
Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study
2022-06-0110
OAAI
Distribution Of Predicted Cardiovascular And All-cause Mortality Benefit Of Intensive Vs Standard Blood Pressure Control Among Us Adults Eligible For The Systolic Blood Pressure Intervention Trial
2021-09-010
PRE